Menu
Peptides Dosage Chart: Timing + Location + Stacks (40 Top)
- Dr. Mohammed Fouda
- Updated On March 27, 2023
We spent 20+ hours reading research papers, perusing clinicical websites and browsing research peptide brands to come up with the ULTIMATE express guide to current up-to-date medical literature on peptide usage, dosage, cycles timing, indications, forms, and studies.
For allfirst time peptide users we know its daunting and intimidating, hopefully this gives you a better idea of what the f*** is going on with most peptides, but remember to exercise caution and consult with your doctor prior to any usage.
Below the individual peptides we’ve added sections on stacks, and we’ve also explained what all the columns mean below. If you want to learn more about an individual peptides click on it or view all our peptide guides below the peptide chart!
Warning: The content on Muscleandbrawn.com and the information included in this article is intended for entertainment and informational purposes only. It is not intended nor implied to be a substitute for professional medical advice. Prior to buying anything, check that it is compliant where you live with your current government laws.
Scroll left and right to see the full chart if your screen is not big enough
| Peptides | 💊 Studied Dosage | 💉 Injection Site | ⏳️ Typical Cycle Length | 🕑 Timing of Dose | ✅ Use/Indication | 🛒 Forms | 📚 Recent Studies |
| Click on peptide for full breakdown | *In accordance with the limited clinical trials and Reddit discussions* | *In accordance with the limited clinical trials and Reddit discussions* | *Based purely on user experiences* | *In accordance with the limited clinical trials and Reddit discussions* | *Based on what Peptide Vendors offer* | *Pubmed and Google Scholar* | |
| Individual Peptides | |||||||
| A | |||||||
| Anamorelin | 100 mcg/day | Not Applicable | 12 Weeks | Before Meals | Cancer Cachexia, Appetite | Oral | [1] [2] [3] |
| ARA 290 | 5 mg/day | Subcutaneous (multiple skin sites) | 4-5 Weeks | Variable | Neuropathic Pain | Injectable | [1] [2] |
| AOD 9604 | 300 mcg/day | Subcutaneous (multiple skin sites) | 20 Days | In Morning- 30 mins prior to eating | Body Fat | Powders, Spray | [1] [2] |
| B | |||||||
| BPC-157 | 1-10 mcg/kg of bodyweight | Subcutaneous, IM | 4-12 Weeks | Before meal and before bed | Anti-inflammatory, Wound healing | Capsules, Injections, Sublingual and dermal Patches | [1] [2] [3] |
| C | |||||||
| Cerebrolysin | Depends on the purpose of intake | IM, IV | Variable | No Specific Timing | Senile/Vascular Dementia, Cerebrovascular disorder | Injectable | [1] [2] |
| CJC 1295 | 30-60 mcg/day | Subcutaneous (multiple skin sites) | 12 Weeks | Before bed- 2 hrs after last meal | Muscle growth, Fat loss | Injectable | [1] [2] |
| D | |||||||
| DSIP | 100-200 mcg/day | Subcutaneously, IV, IM | Variable | 1-3 hours before bed | Irregular Circadian Rhythm, Insomnia | Powder | [1] [2] [3] |
| E | |||||||
| Epitalon | 5-10 mg | Subcutaneously, IV, IM | 2-3 Weeks | Morning- 30 mins prior to eating | Anti-Aging | Capsule, Injectable Nasal Spray | [1] [2] [3] |
| F | |||||||
| Follistatin 344 | 50-100 mcg/day | Subcutaneously, IV, IM | 10-30 days | No Specific Timing | Muscle Growth, Endurance | Powder, Liquid | [1] [2] [3] |
| G | |||||||
| GHK-CU | 0.2 ml/day | Subcutaneous (multiple skin sites) | Variable | No Specific Timing | Wound Healing, Anti-inflammatory | Injectable, Transdermal | [1] [2] |
| GHRP-2 | 150-300 mcg/day | Subcutaneous(Abdomen) | 12-14 Weeks | An hour before Meal | Muscle Growth, Rapid Healing | Injectable, Capsules | [1] [2] [3] |
| GHRP-6 | 100-150 mcg/day | Subcutaneous(Abdomen) | 12-14 Weeks | 30 Minutes Before Meal | Muscle Growth, Rapid Healing | Injectable, Capsules | [1] [2] |
| H | |||||||
| Hexarelin | 200-300 mcg/day | Subcutaneous(Abdomen) | 12-16 Weeks | Before Meals | Muscle building, Fat loss, rapid recovery | Injectable, Tablets | [1] [2] |
| HGH Frag | 200 mcg/day | Subcutaneous, IV | 4-8 Weeks | Before Workout | Obesity, Muscle Mass | Injectable, Tablets | [1] [2] [3] |
| I | |||||||
| IGF-1 | 20-100 mcg/day | Subcutaneous (multiple skin sites) | 4 Weeks | After Workout | Lean Muscle Mass, Fat loss | Injectable | [1] [2] [3] |
| IGF-1 LR3 | 20-40 mcg/day | Subcutaneous (multiple skin sites) | 4 Weeks | Before Workout | Muscle Mass, Bodybuilding | Injectable | [1] [2] [3] |
| Ipamorelin | 200 mcg/day | Subcutaneous, IM | 60-90 Days | Before bed- 2 hrs after last meal | Muscle growth, Fat loss | Injectable | [1] [2] [3] |
| K | |||||||
| KPV | 200-400 mcg/day | Subcutaneous (multiple skin sites) | 4 Weeks | No Specific Timing | Anti-inflammatory, Wound healing | Injectable, Oral Sprays, Creams, Capsules | [1] [2] |
| Kisspeptin 10 | 5-10 mg/day | IV | 4 Months | No Specific Timing | Infertility | Injectable, Capsules | [1] [2] [3] |
| L | |||||||
| ll-37 | 100 mcg/day | Subcutaneous (multiple skin sites) | 2-4 Weeks | No Specific Timing | Anti-microbial | Injectable | [1] [2] |
| Lenomorelin | 7.5 mcg/kg of body weight | Subcutaneous (multiple skin sites) | 10-12 Weeks | Before Meal | Appetite, Strength | Injectable | [1] [2] [3] |
| M | |||||||
| Macimorelin | 0.5 mg/kg of body weight | Not Applicable | Usually a single dose | 8 hours of fasting before use | Fat loss, Muscle Mass | Oral Granules | [1] [2] [3] |
| Melanotan I | 0.25-2 mg/day | Subcutaneous, IM | Variable | No Specific Timing | Skin tanning, Erythropoetic Protoporphyria | Injectable, Nasal Sprays | [1] [2] |
| Melanotan II | 0.25-2 mg/day | Subcutaneous, IM | Variable | No Specific Timing | Erectile Dysfunction & Skin Tanning | Injectable, Nasal Sprays | [1] [2] [3] |
| Mots-c | 1ml/thrice weekly | Subcutaneous (multiple skin sites) | 4 Weeks | No Specific Timing | Metabolic Felxibility, Osteroporosis | Injectable | [1] [2] |
| MGF | 200 mcg/day | Subcutaneous (multiple skin sites) | 4 Weeks | Before Workout | Muscles growth, Tissue Repair | Injectable | [1] [2] |
| P | |||||||
| Peg MGF | 5 mg/day | Subcutaneous (multiple skin sites) | 4 Weeks | No Specific Timing | Endurance, Boosts Immune System | Injectable | [1] |
| Pentosan | 100-250 mg/day | IM, Intra-auricular | 1-6 Months | 1-2 hrs after Meals | Cardiovascular Complications, Joint Pain | Injectable, Capsules, Oral Suspensions | [1] [2] [3] |
| PTD-DMB | 30 ml/day | Not Applicable | Variable | No Specific Timing | Hair loss, Hair Regeneration | Hair Sprays | [1] |
| PT-141 | 1-2 mg | Subcutaneous (multiple skin sites) | 8 times/month | 1-5 hrs before intercourse | Libido & Erectile dysfunction | Injectable, Nasal Sprays, Pills | [1] [2] [3] |
| R | |||||||
| RU 58841 | 50 mg/day | Not Applicable | Variable | After Showering- On dry hair | Hair Loss, Male Pattern Baldness | Powder, Liquid (Topical application) | [1] [2] [3] |
| S | |||||||
| Semaglutide | 0.25 mg/week | Subcutaneous (multipe skin sites) | 4 Weeks | No Specific Timing | Weight Loss, Appetite | Injectable | [1] [2] [3] |
| Sermorelin | 10-20 mcg/kg of body weight | Subcutaneous, IV | 3-6 Months | Before bed | Muscle Mass, Fat Loss | Injectable | [1] [2] [3] |
| Semax | 0.3-1 ml/twice weekly | Subcutaneous (multipe skin sites) | Variable | No Specific Timing | Neuroprotective, Stress-protective | Injectable | [1] [2] [3] |
| T | |||||||
| TB 500 | 7.6 mg/week | IM, IV, Subcutaneous | 2-6 Weeks | Once a Week | Anti-inflammatory & Muscle Growth | Capsules, Injectable, Patches | [1] [2] [3] |
| Tesamorelin | 2 mg/day | Subcutaneous (multipe skin sites) | 2 Months | Before bed- 2 hrs after last meal | HIV- lipodystrophy | Injectable | [1] [2] [3] |
| Thymosin Alpha-1 | 0.8-6.4 mg/twice weekly | Subcutaneous (multipe skin sites) | 6-12 Months | No Specific Timing | Immunocomproised disorders, autoimmune diseases | Injectable, Nasal Sprays | [1] [2] [3] |
| Thymosin Beta-4 | 2-12 mg/day | IM, Subcutaneous | 3-6 Months | Injected close to the site of injury | Wound healing, Anti-inflammatory | Powder, Injectable | [1] [2] [3] |
| V | |||||||
| Vasoactive Intestinal Peptide | Depends on the purpose of intake | IV, Intracavernously | Variable | No Specific Timing | Anti-inflammatory, COPD, Pulmonary Arterial HTN | Injectable | [1] [2] [3] |
| Z | |||||||
| Zn-Thymulin | 1 ml/day | Subcutaneous, IM | Variable | At Night | Hair Loss, Hair pigmentation | Topical Use | [1] [2] |
| Peptide Stacks | |||||||
| BPC-157= 500 mcg/day, TB-500= 5 mg/twice weekly | Subcutaneous, IM | 4 Weeks | Before Meal | Healing, Protein Formation, Muscle Mass | Injectable | ||
| Ipamorelin and CJC-1295 | Ipamorelin= 150mcg/day, CJC-1295= 150mcg/day | Subcutaneous (multiple skin sites) | 4 Weeks | Before Bed | Muscles Growth, Fat loss | Injectable | |
| Melanotan I and Melanotan ll | Melanotan l= 0.25-2 mg/day, Melanotan ll= 0.25-2 mg/day | Subcutaneous, IM | Variable | No Specific Timing | Skin Tanning, Erectile Dysfunction | Injectable, Nasal Sprays | |
| Ipamorelin and Sermorelin | Ipamorelin= 200-300mcg/day, Sermorelin= 200 mcg/day | Subcutaneous (multiple skin sites) | 2-3 Months | Before Bed | Muscles Growth, Fat loss | Injectable | |
| GHRP-6, Sermorelin | GHRP-6= 100 mcg/day, Sermorelin= 100 mcg/day | Subcutaneous(Abdomen) | 3 Months | Before Meal | Fat burn, Endurance, Muscle Mass | Injectable | |
| GHRP6 and CJC-1295 | GHRP-6= 100 mcg/day, CJC-1295= 150mcg/day | Subcutaneous(Abdomen) | 12 Weeks | Before Meal/Bed | Fat loss, Endurance, Strength | Injectable | |
| Semaglutide and AOD 9604 | Semaglutide= 0.25 mg/week, AOD 9604= 300 mcg/day | Subcutaneous (multipe skin sites) | 4 Weeks | Morning | Body Fat, Appetite, Muscle Mass | Injectable | |
| Epitalon and Thymalin | Epitalon= 5-10 mg/day, Thymalin= 10 mg/day | Subcutaneously, IV, IM | 2-3 Weeks | Morning | Strong Immune system, Anti-aging, Anti-inflammatory | Injectable |
All Peptide Guides
What Does Studied Dosage Mean?
The studied dose is the amount of a drug/agent which is proven most efficacious through multiple clinical trials. These trials help evaluate the optimum amount of a given drug that has maximum bioavailability and minimum to induce any negligible side effects.
It is therefore extremely crucial to abide by the correct dosage in order to mitigate the risk of developing any significant adverse effects at the expense of availing maximum benefits.
How Did We Find Typical Cycle Length?
Every peptide is cycled differently by various people. Cycle Length usually indicates the time period during which the drug starts showing its effects in the human body. For peptides, we referred to several clinical trials and user reviews to find the exact cycle length of each peptide.
How Did We Calculate the Timing of Dose?
There’s always a specific time for the intake of the drug alongside certain other precautions. With right timings, you can ensure a drug/supplement’s maximum bioavailability. In order to come up with the right time, we referred to user experiences/reviews as well as scientifically proven research.
What Does Use/Indication Mean?
Use/Indication highlights the purpose behind the intake of the chosen peptide. This is helpful for people to identify the most suitable peptide that would work for them and avoid the rest.
What Are the Recommended Forms to Use?
Recommended forms of peptides depend on the vendor as well as on its half life and bioavailability. Some drugs are only synthesized in injectable or capsule forms. Others can come in creams, skin patches, sprays etc.
While there may be different forms of peptide, it is usually the injectable form that provides the maximum bioavailability. However, injectable form is a strong contraindication in people with bleeding disorders or skin infections.
In general, the recommended form highly depends on the peptide that is being used.
Subscribe
0 Comments
